Global Stem Cell Transplantation Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Stem Cell Transplantation Market was valued at $20.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 11.2% CAGR, to an estimated market size of $34.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global stem cell transplantation market encompasses the collection, processing, storage, and therapeutic infusion of hematopoietic, mesenchymal, and induced pluripotent stem cells to restore biological function or treat diseases. The scope includes both autologous and allogeneic procedures used for malignant hematology, autoimmune disorders, and emerging regenerative medicine applications in neurology and orthopedics.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Stem Cell Transplantation Market in the period 2025-30:
- Integration of gene-editing technologies like CRISPR-Cas9 to enhance the precision and safety of engineered stem cell products.
- A significant shift toward off-the-shelf allogeneic therapies to improve scalability and reduce the high costs associated with patient-specific treatments.
- Increasing adoption of artificial intelligence and machine learning to optimize cell extraction, storage, and large-scale manufacturing processes.
- Expansion of clinical applications beyond oncology into neurological disorders and musculoskeletal repair, driven by regenerative medicine advancements.
- Rising prevalence of hematologic malignancies and chronic diseases in an aging global population, increasing the baseline demand for transplants.
- Growth in public and private cord blood banking, providing a wider registry of diverse donor sources for allogeneic procedures.
- Development of automated bioreactors and closed-system processing to meet stringent GMP-grade manufacturing requirements for cell therapies.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Allogeneic Transplantation
- Autologous Transplantation